News for Biotage AB (BITGF)

Organic Growth: 12% organic growth over the prior year.Reported Growth: 9% reported growth.Drug Discovery and Development Revenue: 349 million SEK, up 13% repo

Oct 23, 2024 / 08:00AM GMTFrederic Vanderhaegen - Biotage AB - CEO and President Afternoon, everyone depending where you are joining us today for the bio dash 2

KKR is reportedly considering selling its 17% stake in Biotage, a Swedish life sciences company.

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Flow Chemistry Market...

Oct 25, 2023 / 01:00PM GMTOperator This call is being recorded. Welcome to Biotage Q3 Report for 2023. (Operator Instructions) Now I will hand the conference ov

Feb 15, 2024 / 02:00PM GMTTorben Jörgensen - Biotage AB - CEO and President Well, welcome to this webinar where we are going to present our Q4 results and al

Rising regulatory compliance for purification process and safety and hygiene and increasing automation and user-friendly designs and use of membrane...

/PRNewswire/ -- The oligonucleotide synthesis market size is estimated to increase by USD 2,870.69 million from 2022 to 2027. The market's growth momentum will...

/PRNewswire/ -- Gamma Biosciences ("Gamma"), a global life sciences platform formed by KKR to address the advanced therapy market with best-in-class...

MENLO PARK, Calif., Feb. 15, 2023 /PRNewswire/ -- Gamma Biosciences , a global life sciences platform formed by KKR to address the advanced therapy market with best-in-class bioprocessing solutions,... | February 15, 2023

/PRNewswire/ -- As per Facts and Factors study, The global Peptide Synthesis market size was estimated to be worth roughly USD 509.74 million in 2021 and is...

Read Stock Analysts’ Downgrades for April 22nd (ACN, AVAV, BITGF, CNI, CRRFY, EXLS, FANUF, FMAO, GOOS, HA) at ETF Daily News